Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
v2i1: pp. 1-16 Jerome S Osteryoung; Kirk Brown; Mark Henniger; Business Valuation and Lost Profits 1992
No products in the cart.